(Q41604155)

4 October 2017

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection (English)

1 reference

4 October 2017

1 reference

1 reference

7

Bertram Wiedenmann

0 references

Alexandra Bergk

5

object named as

Alexandra Bergk

1 reference

4 October 2017

1

Florian van Bömmel

1 reference

4 October 2017

4

Petra Reinke

1 reference

4 October 2017

Thomas Wünsche

2

1 reference

4 October 2017

Stefan Mauss

3

1 reference

4 October 2017

Dirk Schürmann

6

1 reference

4 October 2017

Thomas Berg

8

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

4 October 2017

1 reference

4 October 2017

40

1 reference

4 October 2017

6

1 reference

4 October 2017

1421-1425

1 reference

Long-term therapy of chronic hepatitis B with lamivudine.

4 October 2017

1 reference

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

21 January 2018

1 reference

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

21 January 2018

1 reference

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

21 January 2018

1 reference

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication

21 January 2018

1 reference

Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.

21 January 2018

1 reference

Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.

21 January 2018

1 reference

Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus

21 January 2018

1 reference

Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation

21 January 2018

1 reference

Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'e-minus' patients with YMDD mutations after 4 weeks of tenofovir therapy

21 January 2018

1 reference

Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus

21 January 2018

1 reference

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

21 January 2018

1 reference

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B.

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.20464

1 reference

release_zbtal3dfvff5zf4dyktwkwhtxe

4 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zbtal3dfvff5zf4dyktwkwhtxe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference